Paediatrics studies at 19th International AIDS Conference and the 4th International Workshop on HIV Pediatrics
Polly Clayden HIV i-Base
After a long time languishing in the margins, paediatric HIV has gained a little more attention over the past few years, including a dedicated annual meeting organised by Virology Education, scheduled to precede the IAS one, and now at number four.
Although investigators have the opportunity to submit abstracts to both conferences – so there is some duplication – the workshop provides a very focused update on an area of research that is often harder to find at the big meeting, where basic and clinical science gets eclipsed by rhetoric (particularly where babies and children are concerned).
Presentations and abstracts from this meeting can be found at:
In addition, the Drugs for Neglected Diseases initiative (DNDi), alongside the International AIDS Society-Industry Liaison Forum (IAS-ILF) organised a symposium entitled Catching Children Before They Fall: Addressing Urgent Needs in Developing Drugs for Young Children Living with HIV. This satellite looked at the development of drugs and formulations for infants and young children in resource-limited settings, reflecting DNDi’s recent non-profit R&D work to do exactly that (see below).
Paediatric reports in this issue of HTB include:
- Novel lopinavir/ritonavir sprinkle formulation for children in resource-limited settings
- Update on new antiretrovirals for children and adolescents
- Tenofovir prophylaxis for neonates
- Efavirenz levels variable in children in the CHAPAS-3 study
- High prevalence of peripheral neuropathy in children taking d4T in rural South Africa
- BCG vaccination at birth induces CD4 cell activation in HIV exposed infants
- Lipid profile in children in PREDICT: immediate versus deferred nevirapine-based ART